Case Report
Heart failure secondary to myocarditis after SARS-CoV-2 reinfection: a case report

https://doi.org/10.1016/j.ijid.2021.10.031Get rights and content
Under a Creative Commons license
open access

Highlights

  • Patients vaccinated against COVID-19 may become infected with SARS-CoV-2.

  • Severe heart failure can be identified after myocarditis caused by SARS-CoV-2.

  • Severe cardiac sequelae may be associated with reinfection and COVID-19 vaccination.

Abstract

Introduction

Cardiac involvement in COVID-19 can range from mild damage to severe myocarditis. The precise mechanism by which COVID-19 causes myocardial injury is still unknown. Myocarditis following administration of COVID-19 vaccines, especially those based on mRNA, has also been described. However, no reports of heart failure following reinfection with SARS-CoV-2 in patients immunized with an inactivated vaccine have been identified.

Case description

The patient was a 47-year-old male construction worker of African descent, with type II diabetes and a history of infection by SARS-CoV-2 in December 2020 and May 2021, confirmed by RT-PCR. He received two doses of an inactivated vaccine against COVID-19. Between the two COVID-19 episodes with positive RT-PCR, he had two episodes of bacterial lung infection. After the second episode of SARS-CoV-2 infection, he was diagnosed with severe heart failure as a sequela of myocarditis.

Conclusion

It is essential to perform a thorough follow-up after infection with SARS-CoV-2 since, even with proper immunization, it is possible that the patient was reinfected and suffered severe cardiac sequelae as a consequence. The hypothesis of an etiology associated with the use of an inactivated vaccine against COVID-19, with a potential immune enhancement mechanism following reinfection with SARS-CoV-2, cannot be rejected.

Keywords

COVID-19
SARS-CoV-2
myocarditis
heart failure
vaccine

Cited by (0)